Repka Michael A, Majumdar Soumyajit, Kumar Battu Sunil, Srirangam Ramesh, Upadhye Sampada B
The University of Mississippi, School of Pharmacy, Department of Pharmaceutics, University, MS 38677, USA.
Expert Opin Drug Deliv. 2008 Dec;5(12):1357-76. doi: 10.1517/17425240802583421.
In today's pharmaceutical arena, it is estimated that more than 40% of new chemical entities produced during drug discovery efforts exhibit poor solubility characteristics. However, over the last decade hot-melt extrusion (HME) has emerged as a powerful processing technology for drug delivery and has opened the door to a host of molecules previously considered unviable as drugs. HME is considered to be an efficient technique in developing solid molecular dispersions and has been demonstrated to provide sustained, modified and targeted drug delivery resulting in improved bioavailability. This article reviews the range of HME applications for pharmaceutical dosage forms, such as tablets, capsules, films and implants for drug delivery through oral, transdermal, transmucosal, transungual, as well as other routes of administration. Interest in HME as a pharmaceutical process continues to grow and the potential of automation and reduction of capital investment and labor costs have made this technique worthy of consideration as a drug delivery solution.
在当今的制药领域,据估计在药物研发过程中产生的新化学实体中,超过40%具有较差的溶解性特征。然而,在过去十年中,热熔挤出(HME)已成为一种强大的药物递送加工技术,为许多以前被认为不适合作为药物的分子打开了大门。HME被认为是开发固体分子分散体的有效技术,并已被证明能提供持续、改良和靶向的药物递送,从而提高生物利用度。本文综述了HME在药物剂型中的应用范围,如用于口服、透皮、经粘膜、经指甲以及其他给药途径的片剂、胶囊、薄膜和植入剂等药物递送剂型。作为一种制药工艺,人们对HME的兴趣持续增长,并且自动化以及降低资本投资和劳动力成本的潜力使这项技术值得作为一种药物递送解决方案加以考虑。